<DOC>
	<DOC>NCT00485537</DOC>
	<brief_summary>Cycles with GnRH agonist and GnRH antagonist were compared and main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates, were analized.</brief_summary>
	<brief_title>Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles</brief_title>
	<detailed_description>160 women were equally divided between a GnRH antagonist protocol (Group 1) versus a GnRH agonist protocol (Group 2) in ICSI cycles. The trial was conducted between September 2005 and December 2006. The mean age in both groups was 32 (range 22-40). The main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates.</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Infertility couples, absence of endometriosis (confirmed by a previous surgical procedure to investigate infertility), polycystic ovarian syndrome, FSH levels &lt; 12 IU/l, basal levels of estradiol &lt; 20 in the group submitted to the agonist protocol and beginning of stimulation on day 2 in group submitted to antagonist protocol, in the absence of ovarian cysts on the endovaginal ultrasound use of exogenous LH during stimulation</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>ICSI</keyword>
	<keyword>miscarriage rate</keyword>
	<keyword>pregnancy outcome</keyword>
</DOC>